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Abstract
Objectives To explore the feasibility of using a simple
multi-criteria decision analysis method with policy makers/
key stakeholders to prioritize cardiovascular disease (CVD)
policies in four Mediterranean countries: Palestine, Syria,
Tunisia and Turkey.
Methods A simple multi-criteria decision analysis
(MCDA) method was piloted. A mixed methods study was
used to identify a preliminary list of policy options in each
country. These policies were rated by different policy-
makers/stakeholders against pre-identified criteria to
generate a priority score for each policy and then rank the
policies.
Results Twenty-five different policies were rated in the
four countries to create a country-specific list of CVD
prevention and control policies. The response rate was
100 % in each country. The top policies were mostly
population level interventions and health systems’ level
policies.
Conclusions Successful collaboration between policy
makers/stakeholders and researchers was established in this
small pilot study. MCDA appeared to be feasible and
effective. Future applications should aim to engage a lar-
ger, representative sample of policy makers, especially
from outside the health sector. Weighting the selected
criteria might also be assessed.
Keywords Multi-criteria decision analysis 
Priority setting  Decision-making process 
Low middle income countries  Cardiovascular diseases
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Introduction
Non-communicable diseases (NCDs), including cardio-
vascular diseases (CVDs), are the leading causes of death
worldwide with 80 % occurring in low and middle income
countries (LMIC) (WHO 2011). According to the World
Health Organization (WHO), deaths from NCDs—if not
targeted—will increase by 17 % globally and by 25 % in
the Eastern Mediterranean region (EMR) in the coming
10 years (WHO 2008). CVDs constitute a major proportion
of the NCDs, making them the number one leading cause
of death in most LMIC and the EMR. Most deaths occur at
socially and economically active ages (Miranda et al.
2008), with 29 % of deaths occurring before the age of 60
in LMIC (WHO 2011). Although morbidity data are scarce
and not always reliable in LMIC, the available data suggest
increasing burden of CVDs (Abu-Rmeileh et al. 2012). In
most LMIC, the populations are highly exposed to known
CVD risk factors and appropriate prevention programmes
are not always established. Evidence from some Arab EMR
countries shows an increase in CVD risk factors—includ-
ing smoking, overweight, obesity and physical inactivity
(Jabbour et al. 2012).
The importance of NCDs and their impact not only on
health but on social and economic life are well recognized.
However, the outcomes reflect a gap between the burden of
NCDs and the strategies adopted. In the EMR, policies
targeting the major NCDs and their risk factors are limited,
and when available, the implementation process is gener-
ally fragmented and poorly coordinated (Jabbour et al.
2012). Hence, there is an urgent need to identify and set
priorities within local decision-making processes. That
might not be an easy task, taking into consideration the
dual burden of communicable and NCDs in LMIC, the
limited financial resources and the competing priorities
(Gibson et al. 2004).
Setting priorities and decision-making are multi-
dimensional processes. Different models to explain the
decision-making processes are available. Evidence-based
research should play a critical role in the decision-making
and priority-setting process by providing evidence on the
effectiveness and efficiency of alternative policies (Mendis
and Alwan 2011). In the field of public health, evidence has
demonstrated that decision-makers alone are often not
‘‘well placed’’ to make informed decisions. They some-
times set priorities on an ad hoc basis and not based on
clear evidence (Baltussen and Niessen 2006). Also previ-
ous experiences in utilizing research findings in decision-
making processes have highlighted gaps between research
findings and adopted policies. Such gaps might be due to
the academic style of reporting results which might not be
well understood by decision-makers; research results that
are not timely; and long lists of researchers’ recommen-
dations (AHPSR 2004).
Although perceived to be an important issue, there is no
consensus on how priority setting should be done. More-
over, in a context of wide range of needs and limited
resources, there should be a rational way to trade-off
between different priorities and select the most important
and relevant to local needs. Even if reliable data on
effectiveness and cost-effectiveness of these interventions
are available, still there is a need to consider ethical and
social concerns in selecting the most appropriate one. This
has demonstrated the requirement for multiple criteria to
set priorities and highlighted the need for a methodology to
utilize multiple dimensions of information in decision-
making, and yet be relatively conclusive and straightfor-
ward to implement (Baltussen et al. 2007; Koopmanschap
et al. 2010).
In this context, different methods have been proposed
starting from simple checklists and guidelines to more
complicated approaches such as economic evaluation
(Kapiriri and Norheim 2004). These include but are not
limited to the WHO stepwise framework (Epping-Jordan
et al. 2005), the prioritized research agenda suggested by
the WHO (Mendis and Alwan 2011), the Child Health and
Nutrition Research Initiative (CHNRI) (Rudan et al. 2008),
and the multi-criteria decision analysis (MCDA) (Baltussen
and Niessen 2006).
Multi-criteria decision analysis (MCDA)
MCDA is a method that has been developed in response to
awareness that decision-makers often do not use a rational
approach in decision-making, and criticisms of previous
attempts to prioritize health policies on one criterion only.
In addition to that, many decision-making approaches
rarely considered the societal perspective and the multi-
disciplinary nature of health interventions (Baltussen and
Niessen 2006).
MCDA is defined as: ‘‘a set of methods and approaches
to aid decision-making where decisions are based on more
than one criterion, which make explicit the impact of all the
criteria applied and the relative importance attached to
them’’ (Youngkong et al. 2012a). MCDA has many
applications in marketing, agricultural and environmental
studies, but fewer in health (Youngkong et al. 2012b).
However, MCDA was used as early as 2000 in the Neth-
erlands to assess the most important health problems, as
well as the efficiency of the health care system (Bots and
Hulshof 2000). It has also been used in Nepal (Baltussen
et al. 2007), Thailand (Youngkong et al. 2012a, b), Ghana
(Baltussen et al. 2006) and Uganda (Kapiriri and Norheim
2004).
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The MCDA attempts to explicitly take into account a
range of criteria which decision-makers could use to
inform priority setting and provide a rational approach to
ranking priorities for implementation. The criteria put
forward have varied, but commonly include the ‘‘burden of
disease’’, considerations of ethical, social, equity values
and cost-effectiveness analysis. Methods of analysis
included both qualitative and quantitative methods and also
vary from simple summation to complex weighting and
multi-variable analysis. Whilst a significant body of
research has discussed the potential benefits of MCDA for
health decision-makers, relatively little empirical research
has attempted to assess the feasibility of using such
methods in practice (Baltussen and Niessen 2006).
This paper discusses the process and the feasibility of
using a simple MCDA approach to rank a list of CVD
policies with key decision-makers/stakeholders in four
EMR countries: Palestine, Syria, Tunisia and Turkey. The
four countries are middle income countries facing a critical
and growing burden of NCDs, in addition to many other
health system-related challenges (Maziak et al. 2013). This
setting is optimal to pilot the MCDA.
Methods
The methodology of this study was based on a simple
MCDA framework applied in four EMR countries (Pales-
tine, Syria, Tunisia and Turkey). It included four major
steps (see Fig. 1). These steps are described below.
Selection of CVD prevention and control policies/
interventions
The initial list of CVD prevention and control policies that
were prioritized in this study arose from a multinational
research that involved the four countries—the Med-
CHAMPS study (Mediterranean Studies of CVD and
Hyperglycaemia, Analytical Modeling of Population
Socio-economic transitions project). MedCHAMPS was
conducted in the four countries between 2009 and 2013.
The overall aim of the MedCHAMPS project was to advise
on the policies most likely to be effective in reducing the
burden of CVD and diabetes in these countries. The
methodological details have been published elsewhere
(Maziak et al. 2013; Bowman et al. 2012). In brief, the
project developed a mixed methods framework, including
the involvement of key decision-makers/stakeholders to
generate an expanded list of policy options for the pre-
vention and control of CVDs in each country. The
qualitative methods included a country-specific situational
analysis (Phillimore et al. 2013) and the quantitative
adapted the widely used CHD IMPACT mortality model
for this region (Abu-Rmeileh et al. 2012). Combining
results from this mixed methods-based study in the four
countries generated a list of 32 different CVD prevention
and control policies targeting four different levels: (1)
general population level policies (primary prevention), (2)
policies targeting high risk groups (primary prevention),
(3) patient treatment policies (interventions focused on the
use of pharmaceutics such as multi-drug regimen for pri-
mary or secondary prevention) and (4) policies targeting
the health system (see Supplementary Appendix 1). How-
ever, country-specific lists had lesser policies. In addition,
there was an assumption based on extensive field experi-
ence of the research teams that long lists will affect the
response (i.e. decision-makers will avoid completing
questionnaires that appear too detailed). In an attempt to
make the lists as concise as possible, the research teams
from each country shortlisted a list of 10–20 CVD pre-
vention and control policies (from the 32) that they
considered most relevant to their countries. The researchers
based their selection on knowledge gained through con-
ducting a comprehensive situational analysis in each
country (Phillimore et al. 2013), in addition to previous
experience.
Criteria
Taking into consideration each country’s needs, and dif-
ferent ethical, social and equity values, five different
criteria were identified to rate different CVD prevention
and control policies in our study. These were based on the
WHO stepwise framework, (Epping-Jordan et al. 2005),
and the prioritized research agenda for the prevention and
control of NCDs (Mendis and Alwan 2011). The WHO
stepwise framework proposes a multi-step framework to
assist organizations in identifying and prioritizing evi-
dence-based interventions, whilst the WHO prioritized
Fig. 1 Adapted framework for the multi-criteria decision analysis
(MCDA) applied in four eastern Mediterranean countries (2011)
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research agenda aimed to provide some guidelines on the
national NCD research priorities and a way of translating
research into practice. In addition, criteria were also based
on input from researchers, decision-makers and key infor-
mants (Phillimore et al. 2013), an approach which has been
trialled previously (Baltussen et al. 2006; Kapiriri and
Norheim 2004). These criteria were as follows accept-
ability by the general population, affordability for
governments to implement with the available resources,
feasibility in low resources settings (Mendis and Alwan
2011), availability of such policies in the country and the
estimated time of application (core/expanded/desirable)
(Epping-Jordan et al. 2005). Table 1 summarizes the
selected criteria. A metric-based approach was used to
score the selected policies. A score on a scale of 0–5 was
proposed for each of the five criteria to be evaluated by
decision-makers/key stakeholders (Viergever et al. 2010),
except for the availability criterion, and it was scored as
dichotomous in which 0 score was given to available policy
and five was given to missing one. Although burden of
disease and cost-effectiveness criteria are both important in
such analysis, they were excluded from this MCDA for
scientific or practical reasons. The burden of disease was an
important component already used in shortlisting the pol-
icies (part of the MedCHAMPS prior situational analysis)
(Phillimore et al 2013). And the shortage of data and
decision-maker’s lack of understanding of cost-effective-
ness analyses limited their use in this study.
Selection of decision-makers/stakeholders and process
of getting their feedback
To evaluate CVD prevention and control policies, a form
was developed containing the policies and the criteria to be
shared with decision-makers/stakeholders (see Supple-
mentary Appendix 2). At least, five decision-makers/
stakeholders per country were approached to score the
policies. They were selected from pre-identified lists that
were prepared in a previous stage of the MedCHAMPS
project (Phillimore et al. 2013). In selecting the decision-
makers, we aimed to cover multiple levels of the hierarchy
of the local decision-making process within the health
system. We also attempted to ensure ‘‘diversity’’ in terms
of geographical location, roles in the health system, gender,
type of provider and others. Based on that, decision-
makers/stakeholders were individuals involved in national
decision-making (such as the head of primary health care
divisions) and individuals involved in implementation
(such as regional officers, heads of subdivisions, pro-
gramme coordinators), practitioners (physicians, nurses)
and senior academic researchers (see Table 2).
The forms were shared with the decision-makers/stake-
holders, either during face-to-face interviews (Syria, Tunisia)
or by fax/email (Palestine, Turkey). The criteria and scoring
process were explained and discussed with them face-to-face
or by telephone, and then they were asked to rate the policies
against the criteria mentioned. All those approached returned
Table 1 Selected criteria against which cardiovascular diseases (CVD) prevention and control policies were rated in a multi-criteria decision
analysis (MCDA) applied in four eastern Mediterranean countries (2011)
Criteria Definition Scoring Source/reference
Acceptability Acceptability of implementing such
intervention by the general population
0: Not acceptable
5: Totally acceptable
WHO Prioritized Research Agenda for
Prevention and Control of
Noncommunicable Diseases
Affordability If it is affordable to implement such
policy taking into consideration the
current resources
0: Not affordable
5: Totally affordable
Researchers/key informants
Availability If the policy is available (fully or
partially) or missing
0: Available
5: Missing
Researchers/key informants
Feasibility Feasibility of application in low resources
setting
0: Not feasible
5: Totally feasible
WHO Prioritized Research Agenda for
Prevention and Control of
Noncommunicable Diseases
Core/expanded/desirable Core related to policies that can be
implemented in a short term period
(5 years) with the available resources.
Expanded refers to polices that can be
implemented within a medium term
(around 10 years) with the projected
available resources.
Desirable refers to evidence-based
polices that are beyond the application
with the existing or projected resources
in the long term (more than 15 years)
0: Desirable
3: Expanded
5: Core
WHO Prioritized Research Agenda for
Prevention and Control of NCDs and
WHO stepwise framework
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the completed scores within a 2-week period. The forms were
translated into Arabic (the official language) and cross-
checked in three of the four countries: Palestine, Syria and
Tunisia. In Turkey, the English version was used.
Developing the performance matrix and prioritizing
CVD prevention and control polices
A tabular summary or ‘‘performance matrix’’ showing the
evaluation of each CVD prevention and control policy against
each criterion was produced. (Baltussen and Niessen 2006).
The selected policies on different levels (rows), countries and
criteria (columns) were included in the performance matrix
(see Supplementary Appendix 3). ‘‘A simple linear additive
evaluation model’’ was adopted to calculate the overall pri-
ority score for each policy for each country. The un-weighted
sum for the scores was used to represent the priority score for
each policy assessed; the score could therefore range from
0–25. The use of weights for different criteria has been dis-
cussed in MCDA, but in the absence of any empirical evidence
to attach weights to different criteria, we used an un-weighted
model. Based on these priority scores, the policies were
ranked in terms of their importance.
This paper highly focuses on steps 3 and 4 of the MCDA
as applied during the MedCHAMPS study since steps 1 and
2 were covered previously (Phillimore et al. 2013; Abu-
Rmeileh et al. 2012; Maziak et al. 2013).
Results
From a pre-identified list of CVD prevention and control
policies (32) operating on four main different levels
(Supplementary Appendix 1), country-specific policies
were selected by the research team for further consider-
ation with decision-makers/stakeholders. A list of 25
overlapping policies was selected as follows: 19 policies in
Palestine, Syria and Tunisia and 13 policies in Turkey.
Following the scoring methodology described above, pri-
ority scores were identified for each policy.
Table 3 summarizes the ranges for the priority scores by
country. The priority score varied from a minimum of 12.3
(Turkey) to a maximum of 23.0 (Palestine). The range
varied from 7.7 in Palestine to 10.1 in Syria. The results
were accumulated in the upper half of the distribution
indicating homogenous high perceived importance of most
proposed CVD prevention and control policies. Figure 2
presents all the policies for the four countries highlighting
the similarities and differences between their priorities.
Another way to summarize the resulting scores is by
plotting each policy against its priority score in ascending
order. This is a visual representation of the most important
policies for each country (Fig. 3).
There was some heterogeneity in the policies ranked
highest in each country. At the general population level,
leading policies were, raising awareness of NCDs in Syria
and Tunisia, blood pressure reduction policy through
early screening and information campaigns in Palestine
and tobacco control in Turkey. Among policies targeting
high risk groups, leading policies were as follows: pri-
mary prevention of diabetes by increasing Metformin
uptake in Turkey and Palestine, and through diet and
behavioural change in Syria. Lifestyle modification
(including diet, exercise, physical activity) was also
ranked highly in Turkey and Tunisia. At the treatment
level, leading policies were as follows: multi-drug
Table 2 List of policy makers/key stakeholders who evaluated car-
diovascular diseases (CVD) prevention and control policies using a
multi-criteria decision analysis (MCDA) in four eastern Mediterra-
nean countries (2011)
Policy makers/key stakeholders Palestine Syria Tunisia Turkey
Director of the primary health
care department/NCD unit—
MoH
1 1 1
Director of diabetes centre/
supervision—Hospital
1 1
Dean of the Faculty of Medicine 1
Director/coordinator of the NCD
centre—MoH
1 1 1
Director of the disease control 1
Director of district diabetes
programme
1
Director, Training and
Rehabilitation department
1
Director, Hospital Management
department
1
General district health director 1
Head of Research Laboratory
‘‘Epidemiology and Prevention
of CVDs’’
1
Head of National Observatory of
New and Emerging Diseases
1
Academics (cardiologists,
endocrinologists)
3
Table 3 Range for priority scores by country for cardiovascular
diseases (CVD) prevention and control policies evaluated using a
multi-criteria decision analysis in four eastern Mediterranean coun-
tries (2011)
Country N* Min Max Range
Palestine 19 15.3 23 7.7
Syria 19 12.6 22.7 10.1
Tunisia 19 12.7 20.6 7.9
Turkey 13 12.3 20.8 8.5
* N number of evaluated polices
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regimens for secondary prevention among high risk
individuals delivered by primary health care level in
Palestine, whilst in Syria, it was the multi-drug regimen
for secondary prevention of CVD patients at the tertiary
level (hospital treatment of CVD patients). In Tunisia,
primary prevention for hypertensive patients using anti-
hypertensive medications was the most important policy,
whilst in Turkey, it was the multi-drug regimen for
secondary treatment of heart failure in the community.
Finally on the health systems’ level, improving collabo-
ration between health care providers was rated as the most
important policy for both Palestine and Syria, whereas
strengthening the primary health care system for CVD
patients was given the highest priority for Tunisia, and
capacity building of human resources specialized in NCD
was rated highest in Turkey.
Fig. 2 Distribution of the four country-specific cardiovascular
(CVD) prevention and control policies by priority score generated
using a multi-criteria decision analysis applied in four eastern
Mediterranean countries (2011). *Policy numbers are as mentioned
in Supplementary Appendix 3: the performance matrix. P Palestine,
S Syria, TN Tunisia, TR Turkey
Fig. 3 Priority scores for
different cardiovascular
diseases (CVD) prevention and
control policy options based on
the multi-criteria decision
analysis (MCDA) methodology
that had been applied in four
eastern Mediterranean countries
(2011). *Policy numbers are as
mentioned in Supplementary
Appendix 3: the performance
matrix
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Discussion
In this study, we piloted an innovative approach, the
MCDA, to rate and prioritize a list of CVD prevention and
control policy options identified as ‘‘needed’’ in four EMR
countries. The process included multiple stages of identi-
fying CVD prevention and control policies, selecting
criteria, rating the policies against the criteria by decision-
makers/stakeholders, identifying the priority scores and
ranking them in terms of their importance. Our findings
suggest that this method is potentially feasible, conclusive
and acceptable by various decision-makers and stakehold-
ers who participated in the study.
The strength of this study lies in the approach adopted
for decision-making. Decision-making is a highly dynamic
process with interaction between different decision-makers
and stakeholders. In selecting priorities for a country,
decision-makers need to identify which diseases to prevent,
for which population, using which intervention and based
on which criteria (Baltussen and Niessen 2006). Much of
the required evidence can and should be based on scientific
evidence. However, research findings and recommenda-
tions are sometimes underutilized by decision-makers/
stakeholders. In this study, we approached both decision-
makers/stakeholders as well as academic researchers. The
collaborative nature of this approach in which the decision-
makers/stakeholders had a key role in adding, modifying
and evaluating the research process helped in reducing the
gap between researchers and decision-makers. Successful
coordination between different partners was established,
and solid networks were created. It is reasonable to assume
that this active role for decision-makers and stakeholders in
the process of identifying the needs will lead to better
understanding of the country-specific situation, although
this needs empirical testing in future studies. In terms of
demonstrating the ability of decision-makers and
researchers to communicate and exchange knowledge and
experience, this exercise was successful, as suggested by
the high response. At the end of the study, a list of CVD
prevention and control policies were generated for each
country. These policies were ranked in terms of their
importance using a simple way that is understandable,
affordable and easy to implement.
Another strength for this study is using multiple criteria
in the decision-making process. Having multiple criteria is
a key step of the MCDA process. Selecting relevant criteria
is a crucial part of the process. The criteria should be
selected based on equity and efficiency (World Economic
Forum 2011) they can be medical and nonmedical
depending on type of policies and aim of the MCDA.
Trade-off between different criteria is needed. This can be
achieved by assigning different weights to different crite-
ria. If it is not possible to set weights for criteria, then using
a linear additive model to sum scores (as in this pilot study)
may be acceptable (Baltussen and Niessen 2006). The
criteria selected for this study were mostly nonmedical and
related directly to availability of resources. More vari-
ability is recommended in future research in order to ensure
coverage of various aspects and needs of the community
when setting priorities. Other criteria that can be consid-
ered in future research include severity of the disease,
which is widely used in priority setting. Effectiveness and/
or cost-effectiveness can also be considered (Youngkong
et al. 2012a). Regarding the number of criteria that should
be used, there is no upper limit, but should be limited in
practice to avoid information overload.
Clear definitions and scoring scales for each criterion
should be identified before implementing the MCDA. The
selected criteria should be context specific and can be
based on expert opinion. Overlapping in some definitions
might lead to redundant results. In our study, there was
some overlap between the ‘‘core/expanded/desirable crite-
rion’’ and the ‘‘feasibility’’ criterion, which could have
been a source of some confusion. Another issue is con-
sidering how to assign weights for different criteria. In real-
life situation, different criteria might not have equal
influence. Various methodologies are available to assign
weights to different criteria. They can start from a simple
focus group discussion to a more complicated discrete
choice experiment (DCE) (Ryan 2004). Some of these
methods have been used in Nepal (Baltussen et al. 2007),
the Netherlands (Koopmanschap et al. 2010), Thailand
(Youngkong et al. 2012b) and Ghana (Baltussen et al.
2006).
Although the contribution of the decision-makers/sta-
keholders in this study was promising, the priority scores
need rethinking. A narrow range for the priority scores was
identified with a minimum score of 12.3/25 (i.e. the priority
scores were accumulated in the upper 50 % of the distri-
bution) (see Fig. 2). This implies that all policies were
rated as being of relatively high importance by decision-
makers and stakeholders. Realistically, especially in
resource-constrained settings, a trade-off between different
policies is highly needed. Previous experiences have shown
limited ability of decision-makers to make such trade-offs
resulting in poor achievements (Baltussen and Niessen
2006), and our pilot reflects this. The narrow range of the
resulting scores might also be related to the limited number
and/or diversity of decision-makers/stakeholders contrib-
uting to the study’s results (five from each country). A
representative national and more diverse sample of differ-
ent levels of decision-makers is usually recommended to
enrich the process and give generalizable results. Further,
patients’ groups and the general public can be included in
the process. For example, in Nepal, 66 respondents shared
in a MCDA to evaluate whether a lung health programme
Priority setting for the prevention and control of cardiovascular diseases
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is effective and should be implemented. These included
decision-makers in health and mid-level health managers—
usually health professionals (Baltussen et al. 2007). In
Thailand, in a MCDA experiment to rank HIV/AIDs
interventions, three groups of raters contributed to the
process: decision-makers highly involved in resource
allocation, people living with HIV/AIDs and community
members (Youngkong et al. 2012b).
Another reason for the narrow range might be the scope
of decision-makers/stakeholders who participated. They
were from different fields, ranging from high-level deci-
sion-makers to mid-level managers and practitioners to
academics. However, they were all broadly based within
health systems and services in each country. To further
improve the prioritizing process, expanding the scope of
the decision-makers/stakeholders to include people from
outside the health sector is crucial.
One major challenge in this study was to identify indi-
viduals and/or parties who are aware of, able to identify
and rate the policies against the different criteria. This
study highlighted the immaturity of the multi-sectoral
collaboration approach and its role in the prevention of
disease and improving public health in this region. Multi-
sectoral actions for preventing NCDs are not well estab-
lished in most Arab countries (Jabbour et al. 2012), and
adopting the social determinants model for the prevention
of CVDs is still underutilized (Marmot 2005). It is worth
noting here that most of the global achievements in
reducing CVD risk factors have been achieved outside the
health sector through public policies including trade, food
and pharmaceutical industry, urban development, agricul-
ture, laws, regulations, mass media, fiscal and legislature
(WHO 2008, 2011). All these can be possible targets for
policies that can affect risk factors for CVDs. Some limited
successful examples on multi-sectoral actions for NCDs
prevention through lifestyle modifications exist and can be
models for replication. Those include the NIZWA healthy
lifestyle project in Oman and the Ariana project in Tunisia
(Jabbour et al. 2012).
The deliberation process is also important in latter stages
of the MCDA, after having input from decision-makers.
Whilst the performance matrix allows quantitative analysis
of the performance of the interventions against the criteria,
deliberation between the researchers and/or the decision-
makers/stakeholders provides some clarifications and jus-
tifications of the process and analysis (Youngkong et al.
2012a, b) and by this, the priorities will be set based on
both quantitative and qualitative analyses.
Conclusion
Cardiovascular diseases (CVDs) are a top priority in
LMIC. Multi-criteria decision analysis (MCDA) is a
pragmatic, rapid, participatory appraisal methodology for
setting priorities, which could be easily applied in other
middle income countries. It has many applications in
health, marketing, agricultural and environmental studies.
In this study, MCDA was developed and implemented in
close collaboration with decision-makers and other stake-
holders. Whilst acknowledging several limitations, full
MCDA could be performed to generate evidence-based
priority lists. Given the scarce resources and competing
priorities in health, MCDA appears to be an affordable and
fair decision-making process, and more transparent than
traditional ad hoc processes, which may not formally
consider relevant evidence. Furthermore, MCDA may help
decision-makers to better appreciate the trade-offs between
different criteria for different policies in the decision-
making process.
In this study, only measures of known effectiveness
were shortlisted during the early stages of the process.
Later stages were more influenced by expert (decision-
makers and stakeholders) opinion. We suggest this use of
evidence might be appropriate in LMIC. We recommend
applying this methodology in a systematic way, going
through the different stages described above. Ensuring the
diversity and representation of decision-makers/stake-
holders as a critical component of the MCDA, which—if
applied correctly—can be powerful evidence-based prior-
ity-setting tool.
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